Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives
Biomolecules · 2026
DOI: 10.3390/biom16020225 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Biomolecules, 2026. Verfasst von Shimon Ben-Shabat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Cannabinoids, Neurodegenerative Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation.
Abstract (Originalsprache)
Neurodegenerative diseases are a large and complex group of neurological disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, multiple sclerosis, and so on, which adversely affect the physical and mental health of millions of people globally. Unfortunately, these diseases currently have no cure; only symptomatic treatment is available. Therefore, there is still a growing interest in using cannabinoids to treat neurodegenerative diseases. This systematic review examines the interrelationship between cannabinoids, the blood–brain barrier, and neurodegeneration, and their mutual effects. The objective of this review is to provide an overview of the endocannabinoid system at the neurovascular interface, the alterations and dysregulation of the ECS in neurodegenerative diseases, the interactions of phytocannabinoids with the blood–brain barrier, and their therapeutic potential in the context of neurodegeneration. The findings may facilitate the targeted application of cannabinoids to address multiple aspects of neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
ORCID-Profile: Shimon Ben-Shabat, Ludmila Yarmolinsky, Shir Dayan, Boris Khalfin, Sigal Fleisher-Berkovich
Förderung
- Israel Science Foundation
Zitieren
APA
Ben-Shabat, S., Yarmolinsky, L., Sharon, N., Zeadnaa-Aldda, T., Dayan, S., Khalfin, B., & Fleisher-Berkovich, S. (2026). Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives. Biomolecules. https://doi.org/10.3390/biom16020225
Vancouver
Ben-Shabat S, Yarmolinsky L, Sharon N, Zeadnaa-Aldda T, Dayan S, Khalfin B, et al. Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives. Biomolecules. 2026. doi:10.3390/biom16020225
BibTeX
@article{BenShabat2026,
author = {Ben-Shabat, Shimon and Yarmolinsky, Ludmila and Sharon, Nitzan and Zeadnaa-Aldda, Taima and Dayan, Shir and Khalfin, Boris and Fleisher-Berkovich, Sigal},
title = {Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16020225}
}
EUVIMED